STOCK TITAN

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alaunos Therapeutics (TCRT) announces its participation in the Jefferies 2022 Global Healthcare Conference. The event is scheduled for June 10, 2022, from 9:00-9:25 am ET at the New York Marriott Marquis, Track 6. CEO Kevin S. Boyle Sr. and VP of R&D Drew Deniger, Ph.D. will present. A live webcast will be available on the company's website, with a replay accessible for 90 days post-event. Alaunos focuses on oncology cell therapies utilizing proprietary T-cell receptor technology, collaborating with leading institutes like MD Anderson and the National Cancer Institute.

Positive
  • None.
Negative
  • None.

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research & Development will present at the upcoming Jefferies Healthcare Conference being held on June 8-10, 2022, in New York, NY.

Details for the presentation are below:

Event: Jefferies 2022 Global Healthcare Conference
Date: Friday, June 10, 2022
Time: 9:00-9:25 am ET
Location: New York Marriott Marquis
Room: Track 6

A live webcast of the presentation will be accessible on the Company’s website in the Investors section under Events & Presentations at www.alaunos.com or by using the link here. A replay of the webcast will be available on the Alaunos website for approximately 90 days following the presentation.

About Alaunos Therapeutics
Alaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer technology and its TCR library targeting shared tumor-specific hotspot mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute. For more information, please visit www.alaunos.com.


FAQ

When is Alaunos Therapeutics presenting at the Jefferies Healthcare Conference?

Alaunos Therapeutics will present on June 10, 2022, from 9:00-9:25 am ET.

Where is the Jefferies 2022 Global Healthcare Conference being held?

The conference is taking place at the New York Marriott Marquis.

Who from Alaunos Therapeutics will present at the conference?

CEO Kevin S. Boyle Sr. and VP of R&D Drew Deniger, Ph.D. will present.

Will there be a live stream of Alaunos Therapeutics' presentation?

Yes, a live webcast will be available on Alaunos' website.

How long will the webcast of the presentation be available?

The replay of the webcast will be accessible for approximately 90 days.

Alaunos Therapeutics, Inc.

NASDAQ:TCRT

TCRT Rankings

TCRT Latest News

TCRT Stock Data

20.58M
1.37M
4.39%
17.14%
9.49%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
HOUSTON